How big is the Japan Contraceptive Devices Market?

The Japan Contraceptive Devices Market size is expected to reach USD 638.27 million in 2024 and grow at a CAGR of 5.92% to reach USD 850.94 million by 2029. Read More

What is the current Japan Contraceptive Devices Market size?

In 2024, the Japan Contraceptive Devices Market size is expected to reach USD 638.27 million. Read More

Who are the key players in Japan Contraceptive Devices Market?

Cooper Surgical Inc., Merck & Co., Inc, Bayer AG, Abbvie Inc (Allergan PLC) and Reckitt Benckiser are the major companies operating in the Japan Contraceptive Devices Market. Read More

What years does this Japan Contraceptive Devices Market cover, and what was the market size in 2023?

In 2023, the Japan Contraceptive Devices Market size was estimated at USD 602.60 million. The report covers the Japan Contraceptive Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Contraceptive Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Japan Contraceptive Devices Market Share

Statistics for the 2023 & 2024 Japan Contraceptive Devices market share, created by Mordor Intelligence™ Industry Reports. Japan Contraceptive Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Japan Contraceptive Devices Industry

The Japan Contraceptive Devices Market is fragmented in nature. Moreover, Japan has been witnessing the emergence of some small players due to presence of high awareness. This has also helped the studied market to grow. Some of the market players include Reckitt Benckiser, Cooper Surgical Inc., Abbvie Inc (Allergan PLC), Merck & Co., Inc, Mylan Laboratories, Okamoto Industries, Inc, Pfizer Inc., and Bayer AG.